AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EyePoint Pharmaceuticals, Inc. Director's Dealing 2018

Jun 27, 2018

Director's Dealing

Opens in your device viewer

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2018-06-25

Reporting Person: ANDO GORAN (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-25	Employee Stock Option (right to buy)	$1.93	A	80000	Acquired	2028-06-25	Common Stock (80000)	Direct

F1: The option becomes exercisable in three equal annual installments beginning on June 25, 2019.